Masatoshi Hori MD, Presenter: Nothing to Disclose

Tonsok Kim MD, Abstract Co-Author: Nothing to Disclose

Hiromitsu Onishi MD, Abstract Co-Author: Nothing to Disclose

Makoto Sakane MD, Abstract Co-Author: Nothing to Disclose

Takahiro Tsuboyama MD, Abstract Co-Author: Nothing to Disclose

Noriyuki Tomiyama MD, PhD, Abstract Co-Author: Nothing to Disclose

Mitsuaki Tatsumi MD, PhD, Abstract Co-Author: Nothing to Disclose

Major teaching points of this exhibit are: 1. Novel MRI techniques, such as three-dimensional (3D) TSE sequences, diffusion-weighted imaging, and reduced field-of-view (FOV) diffusion-weighted imaging using spatially selective radio-frequency excitation, are useful for staging and characterizing uterine tumors. 2. Quantitative MRI are promising techniques in evaluating patients with uterine malignancy. 3. It is important to know the role of MRI in the management of patients with uterine malignancies.  

A. Novel MR imaging techniques   A-1. Three-dimensional (3D) TSE sequences   A-2. Value of diffusion-weighted imaging in staging and characterizing uterine tumors   A-3. Reduced FOV diffusion-weighted imaging using spatially selective radio-frequency excitation technique (FOCUS, etc.) B. Quantitative imaging of the uterus   B-1. Intravoxel incoherent motion (IVIM) imaging   B-2. Diffusion kurtosis imaging (DKI)   B-3. Permeability measurements using dynamic contrast-enhanced MRI C. The role of MRI in the management of patients with uterine malignancies   C-1. Radical surgery   C-2. Fertility-preserving treatments   C-3. Radiation therapy D. Conclusion  

http://abstract.rsna.org/uploads/2014/14005254/14005254_35lw.pdf

Hori, M, Kim, T, Onishi, H, Sakane, M, Tsuboyama, T, Tomiyama, N, Tatsumi, M, MR Imaging of Uterus: Novel Imaging Techniques, Quantitative Imaging, and Role in Management.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005254.html